Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entera Bio Ltd. (ENTX) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entera Bio Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1638097.
Total stock buying since 2022: $426,047.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 17,115 | $15,268 | 0 | $0 | 0 | $0 |
| 2023 | 155,904 | $111,304 | 0 | $0 | 0 | $0 |
| 2022 | 188,223 | $299,475 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 17,115 | $15,268 | 0 | $0 | 0 | $0 |
| 2023-12 | 47,904 | $34,010 | 0 | $0 | 0 | $0 |
| 2023-08 | 78,000 | $46,994 | 0 | $0 | 0 | $0 |
| 2023-04 | 30,000 | $30,300 | 0 | $0 | 0 | $0 |
| 2022-11 | 80,000 | $42,500 | 0 | $0 | 0 | $0 |
| 2022-07 | 34,391 | $57,209 | 0 | $0 | 0 | $0 |
| 2022-01 | 73,832 | $199,766 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-12 | Taitel Haya | Buy | 9,500 | .99 | 9,405 |
| 2024-01-10 | Taitel Haya | Buy | 7,615 | .77 | 5,863 |
| 2023-12-22 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 23,952 | .71 | 17,005 |
| 2023-12-22 | Lieberman Gerald M | Buy | 23,952 | .71 | 17,005 |
| 2023-08-22 | Taitel Haya | Buy | 18,000 | .62 | 11,214 |
| 2023-08-21 | Ellis Sean | Buy | 40,000 | .60 | 24,000 |
| 2023-08-21 | Lieberman Gerald M | Buy | 20,000 | .59 | 11,780 |
| 2023-04-04 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 30,000 | 1.01 | 30,300 |
| 2022-11-11 | Ellis Sean | Buy | 30,000 | .53 | 15,900 |
| 2022-11-11 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 50,000 | .53 | 26,600 |
| 2022-07-21 | Ellis Sean | Buy | 14,900 | 1.64 | 24,406 |
| 2022-07-21 | Lieberman Gerald M | Buy | 19,491 | 1.68 | 32,803 |
| 2022-01-20 | Schwartz Phillip (President of R&D) | Buy | 10,000 | 2.52 | 25,250 |
| 2022-01-19 | Ratan Ramesh (U.S.based CFO) | Buy | 10,000 | 2.44 | 24,360 |
| 2022-01-18 | Ellis Sean | Buy | 10,000 | 2.81 | 28,050 |
| 2022-01-18 | Mayron Ron | Buy | 7,000 | 2.80 | 19,600 |
| 2022-01-18 | Lieberman Gerald M | Buy | 2,800 | 2.80 | 7,839 |
| 2022-01-18 | Jamas Spiros (Chief Executive Officer) | Buy | 10,000 | 2.85 | 28,500 |
| 2022-01-14 | Toledano Miranda Jayne | Buy | 6,800 | 2.79 | 18,972 |
| 2022-01-13 | Malca Yonatan | Buy | 7,232 | 2.74 | 19,815 |
| 2022-01-13 | Ostrov Gerald M | Buy | 10,000 | 2.74 | 27,380 |
Insider trading activities including stock purchases, stock sales, and option exercises of ENTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entera Bio Ltd. (symbol ENTX, CIK number 1638097) see the Securities and Exchange Commission (SEC) website.